Anastasia Emmanouilidou
Project Coordinator at Department of Immunology, Genetics and Pathology; Research programme: Molecular Tools and Functional Genomics; Research group Marcel den Hoed
- Mobile phone:
- +46 70 778 99 78
- E-mail:
- anastasia.emmanouilidou@igp.uu.se
- Visiting address:
- BMC, Husargatan 3
751 22 Uppsala - Postal address:
- IGP / BMC
Box 815
751 08 Uppsala
Publications
Recent publications
-
Part of Clinical and Molecular Hepatology, p. 1252-1268, 2025
- DOI for Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease
- Download full text (pdf) of Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease
-
Part of Pharmacological Research, 2025
- DOI for Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD
- Download full text (pdf) of Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD
-
Part of Scientific Reports, p. 5408, 2025
- DOI for Functionally characterizing obesity-susceptibility genes using CRISPR/Cas9, in vivo imaging and deep learning.
- Download full text (pdf) of Functionally characterizing obesity-susceptibility genes using CRISPR/Cas9, in vivo imaging and deep learning.
-
Part of Nature Communications, 2022
- DOI for CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations
- Download full text (pdf) of CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations
-
Part of Nature Metabolism, p. 476-+, 2022
All publications
Articles in journal
-
Part of Clinical and Molecular Hepatology, p. 1252-1268, 2025
- DOI for Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease
- Download full text (pdf) of Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease
-
Part of Pharmacological Research, 2025
- DOI for Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD
- Download full text (pdf) of Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD
-
Part of Scientific Reports, p. 5408, 2025
- DOI for Functionally characterizing obesity-susceptibility genes using CRISPR/Cas9, in vivo imaging and deep learning.
- Download full text (pdf) of Functionally characterizing obesity-susceptibility genes using CRISPR/Cas9, in vivo imaging and deep learning.
-
Part of Nature Communications, 2022
- DOI for CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations
- Download full text (pdf) of CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations
-
Part of Nature Metabolism, p. 476-+, 2022
-
Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity
Part of Genome Biology, 2020
- DOI for Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity
- Download full text (pdf) of Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity
-
Part of Scientific Reports, 2020
- DOI for Translating GWAS-identified loci for cardiac rhythm and rate using an in vivo image- and CRISPR/Cas9-based approach
- Download full text (pdf) of Translating GWAS-identified loci for cardiac rhythm and rate using an in vivo image- and CRISPR/Cas9-based approach